Created at Source Raw Value Validated value
Nov. 16, 2021, 6:30 p.m. usa

require mechanical ventilation have oxygen saturation less than or equal to 89 percent patients re-infected with sars-cov-2 suspected or proven serious active bacterial fungal viral or other infection patients with positive skin test with ip patients with known equine allergies or past medical history of serum sickness patient who are hiv, hcv, hbsag positive or immunocompromised patients with significant co-morbidities at screening moribund state pregnant or nursing women participating in other clinical trial

require mechanical ventilation have oxygen saturation less than or equal to 89 percent patients re-infected with sars-cov-2 suspected or proven serious active bacterial fungal viral or other infection patients with positive skin test with ip patients with known equine allergies or past medical history of serum sickness patient who are hiv, hcv, hbsag positive or immunocompromised patients with significant co-morbidities at screening moribund state pregnant or nursing women participating in other clinical trial

April 10, 2021, 12:31 a.m. usa

1. require mechanical ventilation 2. have oxygen saturation less than or equal to 89 percent 3. patients re-infected with sars-cov-2 4. suspected or proven serious active bacterial fungal viral or other infection 5. patients with positive skin test with ip 6. patients with known equine allergies or past medical history of serum sickness 7. patient who are hiv, hcv, hbsag positive or immunocompromised 8. patients with significant co-morbidities at screening 9. moribund state 10. pregnant or nursing women 11. participating in other clinical trial

1. require mechanical ventilation 2. have oxygen saturation less than or equal to 89 percent 3. patients re-infected with sars-cov-2 4. suspected or proven serious active bacterial fungal viral or other infection 5. patients with positive skin test with ip 6. patients with known equine allergies or past medical history of serum sickness 7. patient who are hiv, hcv, hbsag positive or immunocompromised 8. patients with significant co-morbidities at screening 9. moribund state 10. pregnant or nursing women 11. participating in other clinical trial